Pharmasyntez

Pharmasyntez was founded in 1997 and is the biggest Russian manufacturer of TB medicines. In 2011 Pharmasyntez entered the Top Ten of the Russian Pharma companies according to the ranking of Remedium magazine. Three manufacturing plants of the company produce more than 70 medicinal products in a variety of presentations (capsules, tablets, granules, infusion solutions). Currently Pharmasyntez is working on several investment projects with combined value of over 100 mln USD. At the front line of the development work is Perhlozone®, a new drug which represents a big forward step in TB treatment. The company is open to collaboration with Russian and foreign companies in bringing innovative medicines to the Russian market. You can access the original press release here.